If in the tweet GLS is referred, then 2 points on which I disagree…
A. The GLS management is not going to scale up CDMO materially, they have guided “Aspiration to double % share of the business from current levels by 2027”…not significant I guess, in fact they may not even achieve this aspiration.
B. I doubt if Glenmark Pharma will sell majority of its stake, no doubt they are in need of money to pay off the debt, but will they give up a huge/controlling stake in GLS, I guess not.
| Subscribe To Our Free Newsletter |
